Skip to content

Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 15 (2024)
      • Volume 15 – Issue 1
      • Volume 15 – Issue 2
      • Volume 15 – Suppl. 1
    • VOLUME 14 (2023)
      • Volume 14 – Issue 3
      • Volume 14 – Issue 2
      • Volume 14 – Issue 1
      • Volume 14 – Suppl. 1
    • VOLUME 13 (2022)
      • Volume 13 – Issue 3
      • Volume 13 – Issue 2
      • Volume 13 – Issue 1
      • Volume 13 – Suppl. 1
    • VOLUME 12 (2021)
      • Volume 12 – Issue 1
      • Volume 12 – Issue 2
      • Volume 12 – Issue 3
      • Volume 12 – Suppl. 1
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Category Archives: Volume 9 – Issue 2

PCSK9 administration ameliorates non alcoholic fatty disease in patients with heterozygous familial hyperlipidemia

Aikaterini Dimakopoulou, Georgios Sfikas, Vasilios Athyros

Cost-benefit analysis of mediterranean diet and medication in chronic heart failure patients

Evangelia Tzorovili, Christina Chrysohoou, Evelina Bei, Konstantinos Konstantinou, Androniki Filippou, Stylianos Iosifidis, Demosthenes B. Panagiotakos, Dimitrios Tousoulis

The effects of atorvastatin 30 mg compared with atorvastatin 40 mg in patients with primary hyperlipidemia: a multicenter study

Christos Rizos, Evangelos Liberopoulos, Eleni Mpilianou, Vasileios Kotsis, Nikolaos Tentolouris, Christina Antza, Ioanna Eleftheriadou, Vasileios Tsimihodimos, Moses Elisaf

The role of lipid-lowering treatment in the secondary prevention of ischemic stroke

Eirini Konstantinidou, Konstantinos Tziomalos

CURRENT ISSUE

Abdominal Aortic KLF4 Expression in Hyperlipidemic Rabbits: Impact of Colchicine Regimens
Non-alcoholic fatty liver disease and cardiovascular disease; from epidemiology to clinical and nutrition management: A narrative review

Keywords

acute coronary syndrome (4) Arterial hypertension (4) arterial stiffness (5) Atherosclerosis (20) blood pressure (5) cardiovascular disease (28) cardiovascular diseases (6) Cardiovascular risk (6) childhood obesity (3) coronary artery disease (4) coronary heart disease (4) COVID-19 (4) diabetes (5) diabetes mellitus (9) diet (6) dyslipidemia (14) epidemiology (4) ezetimibe (5) Familial hypercholesterolemia (5) glucose (3) Heart failure (5) hypertension (9) inflammation (10) Ischemic stroke (3) lipoproteins (4) low-density lipoprotein cholesterol (3) Mediterranean diet (8) metabolic syndrome (7) morbidity (3) mortality (8) non-alcoholic fatty-liver disease (5) nonalcoholic fatty liver disease (3) obesity (9) omega-3 fatty acids (3) outcome (3) PCSK9 (3) PCSK9 inhibitors (5) physical activity (4) platelets (8) risk factors (3) smoking (3) statins (15) thrombosis (4) treatment (6) type 2 diabetes mellitus (4)
Journal of Atherosclerosis Prevention and Treatment    ©2025
A SiteOrigin Theme